India has no AlphaFold: Sovereignty will be decided in the architecture of algorithms.

Bharat has been perpetually arriving late to its own argument, crippled with the burden to prove its own inheritance, it has always been armed with evidence instead of authority. This can be seen from the neem case involving W. R. Grace and Company and the basmati claims by RiceTec. Even in 1995, the United States Patent and Trademark Office granted a patent on turmeric’s healing properties to researchers at the University of Mississippi. 

These patents seem ironic because we have known about them through dadi-nani ke nuskhe for ages. For generations, women have been the quiet custodians of healing practices, nutrition, and ecological wisdom while global systems try to monetise fragments of this knowledge. Exhausted by this, the Traditional Knowledge Digital Library was born which digitised centuries of Ayurveda, Siddha, Unani, and yoga that translated the sacred into the bureaucratic so that patent offices in Washington and Munich might recognise what every grandmother in Varanasi already knows. 

Soon with the Biological Diversity (Amendment) Act, 2023, India took a step forward &

Certificates of Registration (CoR) introduced a system of prior control over access to biological resources.This marked a shift from defensive to somewhat offensive policymaking. India is one of 17 megadiverse countries, hosting over 8% of global species on just 2.4% of land. Regions like the Western Ghats and Eastern Himalayas are global biodiversity hotspots.The National Biodiversity Authority, through CoR, is effectively maintaining a national assets register.

In a $300 billion bioeconomy vision, this resource becomes even more critical. In view of this, IPR applications surged from 857 to 1,077 and this is often celebrated as a success. But this may simply reflect compliance rather than innovation. Companies already using biological resources are now formalising paperwork.Filling forms is not the same as creating value.The system looks active, but the deeper question is whether it is future-ready. 

Beacuse recently, AlphaFold is used for predicting protein structures in minutes that once demanded years, mapping biology before a single leaf is touched. This is the second extraction. The first was physical. The second is cognitive. Biology is no longer discovered. It is predicted. And prediction runs on data, not geography.

But while India builds its registry of roots and bark, the world has already moved on to something it cannot touch like Alphafold. The new extraction does not happen at the forest edge. It happens in the upload. Through Digital Sequence Information — the conversion of genetic material into computational data — a seed's entire biological logic can be sequenced, stored in an open-access global database, and deployed in a laboratory halfway across the world, all without ever touching Indian soil.

The Biological Diversity Act, in both its original and amended form, regulates physical biological resources. DSI is neither physical nor, legally speaking, a "biological resource" under current definitions. It is data. And data, as the world has quietly agreed, belongs to whoever can store and use it first. The Nagoya Protocol still has no binding consensus on DSI. Megadiverse countries have pushed for digital sequences to carry the same benefit-sharing obligations as physical genetic material. Developed nations have resisted, sheltering behind "open science." India finds itself in a familiar position: armed with evidence, waiting for authority.

The TKDL protected yoga from a patent in Munich. But can it protect the information extracted from a plant in the Western Ghats, uploaded to a database in Bethesda, and used to develop a pharmaceutical compound that will never acknowledge its origins? The answer is no. India has no AlphaFold. In semiconductors, nations that mastered manufacturing but missed the design layer became permanently dependent. The chip was made in one country; the wealth accumulated in another. The same stratification is emerging in bio-AI. The TKDL has blocked patents and named the theft at the end it is just a library is not a laboratory. 

In coming years AGI will simply accelerate this transformation.  And these laws will feel like VCR regulations in the era of Youtube. The question is no longer who owns the plant. It is who owns the sequence, who builds the model, and who captures the patent on the drug that model predicted. Sovereignty will be decided in the architecture of algorithms. India is not starting from nothing. It is starting from everything. The problem has always been the lag  between what it holds and what it claims, between what it knows and what it builds.

That lag is now assessed in algorithmic cycles. And algorithms, unlike courts, won't really wait....